Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Blood|August 9, 2013
Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR studyFranco Locatelli, Alessandro Crotta, Annalisa Ruggeri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2012
Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolismMary Eapen, Kwang Woo Ahn, Paul J Orchard, et al.
NPJ Genomic Medicine|July 3, 2026
Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancerKate Hetherington, Jacqueline D Hunter, Mark W Donoghoe, et al.
Transfusion|January 21, 2021
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disordersNabanita Bhunia, Rolla Abu-Arja, Joseph R Stanek, et al.
Cancer|June 29, 2023
Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trialBrittany C McGill, Claire E Wakefield, Katherine M Tucker, et al.
Journal of Personalized Medicine|July 29, 2023
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine TrialRebecca Daly, Kate Hetherington, Emily Hazell, et al.
Transplantation and Cellular Therapy|March 19, 2023
Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry StudyJohn Coutsouvelis, Carl M Kirkpatrick, Michael Dooley, et al.
BMJ Open|May 30, 2023
Protocol for a comprehensive prospective cohort study of trio-based whole-genome sequencing for underlying cancer predisposition in paediatric and adolescent patients newly diagnosed with cancer: the PREDICT studyNoemi Auxiliadora Fuentes Bolanos, Bhavna Padhye, Macabe Daley, et al.
American Journal of Hematology|February 18, 2022
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumLauren Pommert, Eric S Schafer, Jemily Malvar, et al.
The Medical Journal of Australia|February 24, 2022
COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statementEliska Furlong, Rishi S Kotecha, Rachel Conyers, et al.
Pageof 8